Related Experiment Videos
Proinsulin in human serum: problems in measurement and interpretation
Clinical Endocrinology
|July 1, 1984
Summary
Immunoradiometric assays for human proinsulin show significant differences in immunoreactivity between pancreatic and biosynthetic forms. Partially cleaved proinsulin intermediates may be preferentially detected in human serum assays.
Area of Science:
- Biochemistry
- Endocrinology
- Immunology
Background:
- Proinsulin is the precursor to insulin, crucial for glucose regulation.
- Immunoassays are vital for measuring proinsulin levels in clinical diagnostics.
- Variations in proinsulin forms can impact assay accuracy.
Purpose of the Study:
- To compare the immunoreactivity of different human proinsulin forms in an indirect immunoradiometric assay.
- To investigate the effect of limited tryptic digestion on biosynthetic human proinsulin's immunoreactivity.
- To understand the implications for proinsulin measurement in human serum.
Main Methods:
- Indirect immunoradiometric assay (IRMA) utilized.
- Extracted pancreatic human proinsulin standard compared with biosynthetic human proinsulin.
- Biosynthetic proinsulin subjected to limited tryptic digestion.
- Analysis of immunoreactivity of pure 65/A1 and 32/33 split proinsulins.
Main Results:
- Extracted pancreatic proinsulin standard exhibited >100-fold higher immunoreactivity than biosynthetic proinsulin.
- Limited tryptic digestion of biosynthetic proinsulin enhanced its immunoreactivity.
- Partially cleaved proinsulin intermediates (65/A1 and 32/33 split) showed high reactivity, similar to the pancreatic standard.
- Intact proinsulin may be poorly recognized by C-peptide antisera.
Conclusions:
- Immunoassays using C-peptide antisera may preferentially detect proinsulin cleavage intermediates, not intact proinsulin.
- Current 'proinsulin' measurements in human serum might primarily reflect these intermediates.
- Assay design and antibody specificity are critical for accurate proinsulin quantification.